UNSPSC 51283926: Sulfaphenazole

This classification denotes a sulfonamide anti-infective agent with the molecular formula C15H14N4O2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0J8L4V3F81, chemically known as sulfanilamide, n(sup 1)-(1-phenylpyrazol-5-yl)- (8ci) but generally known as sulfaphenazole, which bears US NIH Compound Identifier 5335. European Medicines Agency schedules Sulfaphenazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10721MIG. The term SULFAPHENAZOLE is an International Non-Proprietary Name.

UNSPSC 51283926 Sulfaphenazole is a Commodity code that in recent state and local procurement activity encompasses pharmaceutical supplies and medical products sourced through government health and emergency-response programs, though the specific active ingredient sulfaphenazole does not appear in the recent opportunities tagged to this code. Instead, the opportunities show purchasing of naloxone, generic multi-source pharmaceuticals, over-the-counter products, and emergency medical supplies by health departments, fire departments, and state pharmacy benefit programs. Issuing bodies include county health systems (Seminole County, Florida), municipal fire departments (City of Tampa), state health commissions (Texas Health and Human Services Commission), and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance, or MMCAP, serving participating state and local government facilities including Oregon). The Tampa Fire Department procurement represents the most concrete recent activity under this code, soliciting 169 line items of medical and first aid supplies valued at approximately $700,000 for the Rescue Division with a one-year initial term and two optional renewals.

Geographic activity spans Florida, Texas, Minnesota, and Oregon based on the recent opportunities. The City of Tampa's IFB 26P00145 for medical and first aid supplies closed March 13, 2026, and was sheltered as a certified Small Local Business Enterprise (SLBE) set-aside with a 5 percent bid discount not to exceed $10,000. The Minnesota Multistate Cooperative Purchasing Alliance issued RFP S1070000015802 on January 20, 2026, with proposals due March 26, 2026, seeking generic multi-source pharmaceuticals and OTC products through three authorized wholesalers, with awards effective July 1, 2026, and contract terms of two years for new vendors. Seminole County, Florida solicited naloxone and drug deactivation systems under IFB60459723LAS with a due date of July 26, 2023 (note: this opportunity appears misdated relative to its June 2026 posting). Texas HHS issued RFI HHS0017013 on March 27, 2026, with responses due April 3, 2026, to gather market intelligence on direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager and group purchasing organization channels.